Natco Pharma has received final approval from the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets.

Breckenridge had filed its abbreviated new drug application (ANDA) with a Paragraph IV certification to obtain approval to manufacture.

Drug firm Lupin today said the company's US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsule...